Cargando…

Green and efficient one-pot three-component synthesis of novel drug-like furo[2,3-d]pyrimidines as potential active site inhibitors and putative allosteric hotspots modulators of both SARS-CoV-2 M(Pro) and PL(Pro)

In this paper, an environmentally benign, convenient, and efficient one-pot three-component reaction has been developed for the regioselective synthesis of novel 5-aroyl(or heteroaroyl)-6-(alkylamino)-1,3-dimethylfuro[2,3-d]pyrimidine-2,4(1H,3H)-diones (4a‒n) through the sequential condensation of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mousavi, Hossein, Zeynizadeh, Behzad, Rimaz, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883075/
https://www.ncbi.nlm.nih.gov/pubmed/37037129
http://dx.doi.org/10.1016/j.bioorg.2023.106390
_version_ 1784879427537076224
author Mousavi, Hossein
Zeynizadeh, Behzad
Rimaz, Mehdi
author_facet Mousavi, Hossein
Zeynizadeh, Behzad
Rimaz, Mehdi
author_sort Mousavi, Hossein
collection PubMed
description In this paper, an environmentally benign, convenient, and efficient one-pot three-component reaction has been developed for the regioselective synthesis of novel 5-aroyl(or heteroaroyl)-6-(alkylamino)-1,3-dimethylfuro[2,3-d]pyrimidine-2,4(1H,3H)-diones (4a‒n) through the sequential condensation of aryl(or heteroaryl)glyoxal monohydrates (1a‒g), 1,3-dimethylbarbituric acid (2), and alkyl(viz. cyclohexyl or tert-butyl)isocyanides (3a or 3b) catalyzed by ultra-low loading ZrOCl(2)•8H(2)O (just 2 mol%) in water at 50 ˚C. After synthesis and characterization of the mentioned furo[2,3-d]pyrimidines (4a‒n), their multi-targeting inhibitory properties were investigated against the active site and putative allosteric hotspots of both SARS-CoV-2 main protease (M(Pro)) and papain-like protease (PL(Pro)) based on molecular docking studies and compare the attained results with various medicinal compounds which approximately in three past years were used, introduced, and or repurposed to fight against COVID-19. Furthermore, drug-likeness properties of the mentioned small heterocyclic frameworks (4a‒n) have been explored using in silico ADMET analyses. Interestingly, the molecular docking studies and ADMET-related data revealed that the novel series of furo[2,3-d]pyrimidines (4a‒n), especially 5-(3,4-methylendioxybenzoyl)-6-(cyclohexylamino)-1,3-dimethylfuro[2,3-d]pyrimidine-2,4(1H,3H)-dione (4g) as hit one is potential COVID-19 drug candidate, can subject to further in vitro and in vivo studies. It is worthwhile to note that the protein–ligand-type molecular docking studies on the human body temperature-dependent M(Pro) protein that surprisingly contains zinc(II) (Zn(II)) ion between His41/Cys145 catalytic dyad in the active site, which undoubtedly can make new plans for designing novel SARS-CoV-2 M(Pro) inhibitors, is performed for the first time in this paper, to the best of our knowledge.
format Online
Article
Text
id pubmed-9883075
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-98830752023-01-30 Green and efficient one-pot three-component synthesis of novel drug-like furo[2,3-d]pyrimidines as potential active site inhibitors and putative allosteric hotspots modulators of both SARS-CoV-2 M(Pro) and PL(Pro) Mousavi, Hossein Zeynizadeh, Behzad Rimaz, Mehdi Bioorg Chem Article In this paper, an environmentally benign, convenient, and efficient one-pot three-component reaction has been developed for the regioselective synthesis of novel 5-aroyl(or heteroaroyl)-6-(alkylamino)-1,3-dimethylfuro[2,3-d]pyrimidine-2,4(1H,3H)-diones (4a‒n) through the sequential condensation of aryl(or heteroaryl)glyoxal monohydrates (1a‒g), 1,3-dimethylbarbituric acid (2), and alkyl(viz. cyclohexyl or tert-butyl)isocyanides (3a or 3b) catalyzed by ultra-low loading ZrOCl(2)•8H(2)O (just 2 mol%) in water at 50 ˚C. After synthesis and characterization of the mentioned furo[2,3-d]pyrimidines (4a‒n), their multi-targeting inhibitory properties were investigated against the active site and putative allosteric hotspots of both SARS-CoV-2 main protease (M(Pro)) and papain-like protease (PL(Pro)) based on molecular docking studies and compare the attained results with various medicinal compounds which approximately in three past years were used, introduced, and or repurposed to fight against COVID-19. Furthermore, drug-likeness properties of the mentioned small heterocyclic frameworks (4a‒n) have been explored using in silico ADMET analyses. Interestingly, the molecular docking studies and ADMET-related data revealed that the novel series of furo[2,3-d]pyrimidines (4a‒n), especially 5-(3,4-methylendioxybenzoyl)-6-(cyclohexylamino)-1,3-dimethylfuro[2,3-d]pyrimidine-2,4(1H,3H)-dione (4g) as hit one is potential COVID-19 drug candidate, can subject to further in vitro and in vivo studies. It is worthwhile to note that the protein–ligand-type molecular docking studies on the human body temperature-dependent M(Pro) protein that surprisingly contains zinc(II) (Zn(II)) ion between His41/Cys145 catalytic dyad in the active site, which undoubtedly can make new plans for designing novel SARS-CoV-2 M(Pro) inhibitors, is performed for the first time in this paper, to the best of our knowledge. Elsevier Inc. 2023-06 2023-01-28 /pmc/articles/PMC9883075/ /pubmed/37037129 http://dx.doi.org/10.1016/j.bioorg.2023.106390 Text en © 2023 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Mousavi, Hossein
Zeynizadeh, Behzad
Rimaz, Mehdi
Green and efficient one-pot three-component synthesis of novel drug-like furo[2,3-d]pyrimidines as potential active site inhibitors and putative allosteric hotspots modulators of both SARS-CoV-2 M(Pro) and PL(Pro)
title Green and efficient one-pot three-component synthesis of novel drug-like furo[2,3-d]pyrimidines as potential active site inhibitors and putative allosteric hotspots modulators of both SARS-CoV-2 M(Pro) and PL(Pro)
title_full Green and efficient one-pot three-component synthesis of novel drug-like furo[2,3-d]pyrimidines as potential active site inhibitors and putative allosteric hotspots modulators of both SARS-CoV-2 M(Pro) and PL(Pro)
title_fullStr Green and efficient one-pot three-component synthesis of novel drug-like furo[2,3-d]pyrimidines as potential active site inhibitors and putative allosteric hotspots modulators of both SARS-CoV-2 M(Pro) and PL(Pro)
title_full_unstemmed Green and efficient one-pot three-component synthesis of novel drug-like furo[2,3-d]pyrimidines as potential active site inhibitors and putative allosteric hotspots modulators of both SARS-CoV-2 M(Pro) and PL(Pro)
title_short Green and efficient one-pot three-component synthesis of novel drug-like furo[2,3-d]pyrimidines as potential active site inhibitors and putative allosteric hotspots modulators of both SARS-CoV-2 M(Pro) and PL(Pro)
title_sort green and efficient one-pot three-component synthesis of novel drug-like furo[2,3-d]pyrimidines as potential active site inhibitors and putative allosteric hotspots modulators of both sars-cov-2 m(pro) and pl(pro)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883075/
https://www.ncbi.nlm.nih.gov/pubmed/37037129
http://dx.doi.org/10.1016/j.bioorg.2023.106390
work_keys_str_mv AT mousavihossein greenandefficientonepotthreecomponentsynthesisofnoveldruglikefuro23dpyrimidinesaspotentialactivesiteinhibitorsandputativeallosterichotspotsmodulatorsofbothsarscov2mproandplpro
AT zeynizadehbehzad greenandefficientonepotthreecomponentsynthesisofnoveldruglikefuro23dpyrimidinesaspotentialactivesiteinhibitorsandputativeallosterichotspotsmodulatorsofbothsarscov2mproandplpro
AT rimazmehdi greenandefficientonepotthreecomponentsynthesisofnoveldruglikefuro23dpyrimidinesaspotentialactivesiteinhibitorsandputativeallosterichotspotsmodulatorsofbothsarscov2mproandplpro